Singapore-headquartered pharmaceutical company Mundipharma expects to close at least 30 deals to acquire consumer product brands by end of 2018 to strengthen its foothold in the emerging markets including Southeast Asia, said CEO Raman Singh.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
